Crosstalk between Wnt/β-catenin and Hedgehog/Gli signaling pathways in colon cancer and implications for therapy

Cancer Biology and Therapy

Volumn 16, Issue 1, 2015, Pages 1-7

  Song, Li ^a,b   Li, Zhuo Yu ^b,c   Liu, Wei Ping ^a   Zhao, Mei Rong ^d  

^a ZHEJIANG UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c ZHEJIANG CHINESE MEDICAL UNIVERSITY   (China)

^d ZHEJIANG UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

colon cancer; crosstalk; Gli; Hedgehog Gli signaling; therapeutic targets; Wnt catenin signaling; catenin

Indexed keywords

BETA CATENIN; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR GLI1; WNT PROTEIN; ANTINEOPLASTIC AGENT; GLI PROTEIN; ONCOPROTEIN; PROTEIN BINDING; TRANSACTIVATOR PROTEIN;

CANCER THERAPY; CANONICAL WNT SIGNALING; COLON CANCER; HEDGEHOG SIGNALING; HUMAN; PRIORITY JOURNAL; REVIEW; ANIMAL; COLONIC NEOPLASMS; DRUG EFFECTS; METABOLISM; MOLECULARLY TARGETED THERAPY; SIGNAL TRANSDUCTION;

ANIMALS; ANTINEOPLASTIC AGENTS; BETA CATENIN; COLONIC NEOPLASMS; HEDGEHOG PROTEINS; HUMANS; MOLECULAR TARGETED THERAPY; ONCOGENE PROTEINS; PROTEIN BINDING; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS; WNT PROTEINS;

EID: 84961516918     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/15384047.2014.972215     Document Type: Review

References (76)

1. Tian X, Liu Z, Niu B, Zhang J, Tan TK, Lee SR, Zhao Y, Harris DC, Zheng G. E-cadherin/beta-catenin complex and the epithelial barrier. J Biomed Biotechnol 2011; 2011:567305; PMID:22007144
2. Amit S, Hatzubai A, Birman Y, Andersen JS, Ben-Shushan E, Mann M, Ben-Neriah Y, Alkalay I. Axin-mediated CKI phosphorylation of beta-catenin at Ser 45: a molecular switch for the Wnt pathway. Genes Dev 2002; 16:1066-76; PMID:12000790; http://dx.doi.org/10.1101/gad.230302
3. Liu C, Li Y, Semenov M, Han C, Baeg GH, Tan Y, Zhang Z, Lin X, He X. Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell 2002; 108:837-47; PMID:11955436; http://dx.doi.org/10.1016/S0092-8674(02)00685-2
4. Segditsas S, Tomlinson I. Colorectal cancer and genetic alterations in the Wnt pathway. Oncogene 2006; 25:7531-7; PMID:17143297; http://dx.doi.org/10.1038/sj.onc.1210059
5. The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature 2012; 487:330-7; PMID:22810696; http://dx.doi.org/10.1038/nature11252
6. Qi J, Zhu YQ, Luo J, Tao WH. Hypermethylation and expression regulation of secreted frizzled-related protein genes in colorectal tumor. World J Gastroenterol 2006; 12:7113-7; PMID:17131472
7. Li J, Mizukami Y, Zhang X, Jo WS, Chung DC. Oncogenic K-ras stimulates Wnt signaling in colon cancer through inhibition of GSK-3beta. Gastroenterology 2005; 128:1907-18; PMID:15940626; http://dx.doi.org/10.1053/j.gastro.2005.02.067
8. Levina E, Oren M, Ben-Ze’ev A. Downregulation of beta-catenin by p53 involves changes in the rate of beta-catenin phosphorylation and Axin dynamics. Oncogene 2004; 23:4444-53; PMID:15064706; http://dx.doi.org/10.1038/sj.onc.1207587
9. Sadot E, Geiger B, Oren M, Ben-Ze’ev A. Down-regulation of beta-catenin by activated p53. Mol Cell Biol 2001; 21:6768-81; PMID:11564862; http://dx.doi.org/10.1128/MCB.21.20.6768-6781.2001
10. Rychahou PG, Kang J, Gulhati P, Doan HQ, Chen LA, Xiao SY, Chung DH, Evers BM. Akt2 overexpression plays a critical role in the establishment of colorectal cancer metastasis. Proc Natl Acad Sci 2008; 105:20315-20; http://dx.doi.org/10.1073/pnas.0810715105
11. Bowen KA, Doan HQ, Zhou BP, Wang Q, Zhou Y, Rychahou PG, Evers BM. PTEN loss induces epithelial–mesenchymal transition in human colon cancer cells. Anticancer Res 2009; 29:4439-49; PMID:20032390
12. Sawai H, Yasuda A, Ochi N, Ma J, Matsuo Y, Wakasugi T, Takahashi H, Funahashi H, Sato M, Takeyama H. Loss of PTEN expression is associated with colorectal cancer liver metastasis and poor patient survival. BMC Gastroenterol 2008; 8:56; PMID:19036165; http://dx.doi.org/10.1186/1471-230X-8-56
13. Rasola A, Fassetta M, De Bacco F, D’Alessandro L, Gramaglia D, Di Renzo MF, Comoglio PM. A positive feedback loop between hepatocyte growth factor receptor and beta-catenin sustains colorectal cancer cell invasive growth. Oncogene 2007; 26:1078-87; PMID:16953230; http://dx.doi.org/10.1038/sj.onc.1209859
14. Yang L, Lin C, Liu ZR. P68 RNA helicase mediates PDGF-induced epithelial mesenchymal transition by displacing Axin from beta-catenin. Cell 2006; 127:139-55; PMID:17018282; http://dx.doi.org/10.1016/j.cell.2006.08.036
15. O’Brien CA, Pollett A, Gallinger S, Dick JE. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 2007; 445:106-10; http://dx.doi.org/10.1038/nature05372
16. Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C, De Maria R. Identification and expansion of human colon-cancer-initiating cells. Nature 2007; 445:111-5; PMID:17122771; http://dx.doi.org/10.1038/nature05384
17. Vermeulen L, De Sousa EMF, van der Heijden M, Cameron K, de Jong JH, Borovski T, Tuynman JB, Todaro M, Merz C, Rodermond H, et al. Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nat Cell Biol 2010; 12:468-76; PMID:20418870; http://dx.doi.org/10.1038/ncb2048
18. Jacob J, Briscoe J. Gli proteins and the control of spinal-cord patterning. EMBO Rep 2003; 4:761-5; PMID:12897799; http://dx.doi.org/10.1038/sj.embor.embor896
19. Rohatgi R, Milenkovic L, Corcoran RB, Scott MP. Hedgehog signal transduction by Smoothened: pharmacologic evidence for a 2-step activation process. Proc Natl Acad Sci U S A 2009; 106:3196-201; PMID:19218434; http://dx.doi.org/10.1073/pnas.0813373106
20. Rohatgi R, Milenkovic L, Scott MP. Patched1 regulates hedgehog signaling at the primary cilium. Science 2007; 317:372-6; PMID:17641202; http://dx.doi.org/10.1126/science.1139740
21. Wong SY, Seol AD, So PL, Ermilov AN, Bichakjian CK, Epstein EHJr, Dlugosz AA, Reiter JF. Primary cilia can both mediate and suppress Hedgehog pathway-dependent tumorigenesis. Nat Med 2009; 15:1055-61; PMID:19701205; http://dx.doi.org/10.1038/nm.2011
22. Kogerman PGT, Kogerman L, Krause D, Undén AB, Sandstedt B, Toftgård R, Zaphiropoulos PG. Mammalian suppressor of fused modulates nuclearcytoplastic shuttling of Gli1. Nat Cell Biol 1999; 1:312-9; PMID:10559945; http://dx.doi.org/10.1038/13031
23. Ding Q, Fukami S, Meng X, Nishizaki Y, Zhang X, Sasaki H, Dlugosz A, Nakafuku M, Hui C. Mouse suppressor of fused is a negative regulator of sonic hedgehog signaling and alters the subcellular distribution of Gli1. Curr Biol 1999; 9:1119-22; PMID:10531011; http://dx.doi.org/10.1016/S0960-9822(99)80482-5
24. Yoshikawa K, Shimada M, Miyamoto H, Higashijima J, Miyatani T, Nishioka M, Kurita N, Iwata T, Uehara H. Sonic hedgehog relates to colorectal carcinogenesis. J Gastroenterol 2009; 44:1113-7; PMID:19662327; http://dx.doi.org/10.1007/s00535-009-0110-2
25. Wang H, Li YY, Wu YY, Nie YQ. Expression and clinical significance of hedgehog signaling pathway related components in colorectal cancer. Asian Pac J Cancer Prev 2012; 13:2319-24; PMID:22901214; http://dx.doi.org/10.7314/APJCP.2012.13.5.2319
26. Oniscu A, James RM, Morris RG, Bader S, Malcomson RDG, Harrison DJ. Expression of Sonic hedgehog pathway genes is altered in colonic neoplasia. J Pathol 2004; 203:909-17; PMID:15258993; http://dx.doi.org/10.1002/path.1591
27. Bian YH, Huang SH, Yang L, Ma XL, Xie JW, Zhang HW. Sonic hedgehog-Gli1 pathway in colorectal adenocarcinomas. World J Gastroenterol 2007; 13:1659-65; PMID:17461467; http://dx.doi.org/10.3748/wjg.v13.i11.1659
28. Rako I, Jakic-Razumovic J, Katalinic D, Sertic J, Plestina S. Mutation pattern of KRAS and BRAF oncogenes in colorectal cancer patients. Neoplasma 2012; 59:376-83; PMID:22489692; http://dx.doi.org/10.4149/neo_2012_049
29. Mazumdar T, DeVecchio J, Agyeman A, Shi T, Houghton JA. The GLI genes as the molecular switch in disrupting Hedgehog signaling in colon cancer. Oncotarget 2011; 2:638-45; PMID:21860067
30. Varnat F, Siegl-Cachedenier I, Malerba M, Gervaz P, Ruiz i Altaba A. Loss of WNT-TCF addiction and enhancement of HH-GLI1 signalling define the metastatic transition of human colon carcinomas. EMBO Mol Med 2010; 2:440-57; PMID:20941789; http://dx.doi.org/10.1002/emmm.201000098
31. Barakat MT, Humke EW, Scott MP. Learning from Jekyll to control Hyde: Hedgehog signaling in development and cancer. Trends Mol Med 2010; 16:337-48; PMID:20696410; http://dx.doi.org/10.1016/j.molmed.2010.05.003
32. Berman DM, Karhadkar SS, Maitra A, Montes De Oca R, Gerstenblith MR, Briggs K, Parker AR, Shimada Y, Eshleman JR, Watkins DN, et al. Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours. Nature 2003; 425:846-51; PMID:14520411; http://dx.doi.org/10.1038/nature01972
33. Van Den Brink GR, Peppelenbosch MP. Expression of hedgehog pathway components in the adult colon. Gastroenterology 2006; 130:619; PMID:16472622; http://dx.doi.org/10.1053/j.gastro.2006.01.020
34. Qualtrough D, Buda A, Gaffield W, Williams AC, Paraskeva C. Hedgehog signalling in colorectal tumour cells: induction of apoptosis with cyclopamine treatment. Int J Cancer 2004; 110:831-7; PMID:15170664; http://dx.doi.org/10.1002/ijc.20227
35. Varnat F, Duquet A, Malerba M, Zbinden M, Mas C, Gervaz P, Ruiz i Altaba A. Human colon cancer epithelial cells harbour active HEDGEHOG-GLI signalling that is essential for tumour growth, recurrence, metastasis and stem cell survival and expansion. EMBO Mol Med 2009; 1:338-51; PMID:20049737; http://dx.doi.org/10.1002/emmm.200900039
36. Yauch RL, Gould SE, Scales SJ, Tang T, Tian H, Ahn CP, Marshall D, Fu L, Januario T, Kallop D, et al. A paracrine requirement for hedgehog signalling in cancer. Nature 2008; 455:406-10; PMID:18754008; http://dx.doi.org/10.1038/nature07275
37. Varnat F, Zacchetti G, Ruiz i Altaba A. Hedgehog pathway activity is required for the lethality and intestinal phenotypes of mice with hyperactive Wnt signaling. Mech Dev 2010; 127:73-81; PMID:19861162; http://dx.doi.org/10.1016/j.mod.2009.10.005
38. Noubissi FK, Goswami S, Sanek NA, Kawakami K, Minamoto T, Moser A, Grinblat Y, Spiegelman VS. Wnt signaling stimulates transcriptional outcome of the Hedgehog pathway by stabilizing GLI1 mRNA. Cancer Res 2009; 69:8572-8; PMID:19887615; http://dx.doi.org/10.1158/0008-5472.CAN-09-1500
39. Arimura S, Matsunaga A, Kitamura T, Aoki K, Aoki M, Taketo MM. Reduced level of smoothened suppresses intestinal tumorigenesis by down-regulation of Wnt signaling. Gastroenterology 2009; 137:629-38; PMID:19427313; http://dx.doi.org/10.1053/j.gastro.2009.04.059
40. Maeda O, Kondo M, Fujita T, Usami N, Fukui T, Shimokata K, Ando T, Goto H, Sekido Y. Enhancement of GLI1-transcriptional activity by beta-catenin in human cancer cells. Oncol Rep 2006; 16:91-6; PMID:16786128
41. van den Brink GR. Hedgehog Wnteraction in colorectal cancer. Gut 2006; 55:912-4; PMID:16766747; http://dx.doi.org/10.1136/gut.2005.085902
42. Meng X, Poon R, Zhang X, Cheah A, Ding Q, Hui CC, Alman B. Suppressor of fused negatively regulates beta-catenin signaling. J Biol Chem 2001; 276:40113-9; PMID:11477086; http://dx.doi.org/10.1074/jbc.M105317200
43. Hart M, Concordet JP, Lassot I, Albert I, del los Santos R, Durand H, Perret C, Rubinfeld B, Margottin F, Benarous R, et al. The F-box protein beta-TrCP associates with phosphorylated beta-catenin and regulates its activity in the cell. Curr Biol 1999; 9:207-10; PMID:10074433; http://dx.doi.org/10.1016/S0960-9822(99)80091-8
44. Tempe D, Casas M, Karaz S, Blanchet-Tournier MF, Concordet JP. Multisite protein kinase A and glycogen synthase kinase 3beta phosphorylation leads to Gli3 ubiquitination by SCFbetaTrCP. Mol Cell Biol 2006; 26:4316-26; PMID:16705181; http://dx.doi.org/10.1128/MCB.02183-05
45. Wang B, Li Y. Evidence for the direct involvement of {beta}TrCP in Gli3 protein processing. Proc Natl Acad Sci U S A 2006; 103:33-8; PMID:16371461; http://dx.doi.org/10.1073/pnas.0509927103
46. Dunaeva M, Michelson P, Kogerman P, Toftgard R. Characterization of the physical interaction of Gli proteins with SUFU proteins. J Biol Chem 2003; 278:5116-22; PMID:12426310; http://dx.doi.org/10.1074/jbc.M209492200
47. Tukachinsky H, Lopez LV, Salic A. A mechanism for vertebrate Hedgehog signaling: recruitment to cilia and dissociation of SuFu-Gli protein complexes. J Cell Biol 2010; 191:415-28; PMID:20956384; http://dx.doi.org/10.1083/jcb.201004108
48. Kinch MS, Clark GJ, Der CJ, Burridge K. Tyrosine phosphorylation regulates the adhesions of ras-transformed breast epithelia. J Cell Biol 1995; 130:461-71; PMID:7542250; http://dx.doi.org/10.1083/jcb.130.2.461
49. Janssen KP, Alberici P, Fsihi H, Gaspar C, Breukel C, Franken P, Rosty C, Abal M, El Marjou F, Smits R, et al. APC and oncogenic KRAS are synergistic in enhancing Wnt signaling in intestinal tumor formation and progression. Gastroenterology 2006; 131:1096-109; PMID:17030180; http://dx.doi.org/10.1053/j.gastro.2006.08.011
50. Ulloa F, Itasaki N, Briscoe J. Inhibitory Gli3 activity negatively regulates Wnt/beta-catenin signaling. Curr Biol 2007; 17:545-50; PMID:17331723; http://dx.doi.org/10.1016/j.cub.2007.01.062
51. Louro ID, Bailey EC, Li X, South LS, McKie-Bell PR, Yoder BK, Huang CC, Johnson MR, Hill AE, Johnson RL, et al. Comparative gene expression profile analysis of GLI and c-MYC in an epithelial model of malignant transformation. Cancer Res 2002; 62:5867-73; PMID:12384550
52. Stemmer V, de Craene B, Berx G, Behrens J. Snail promotes Wnt target gene expression and interacts with beta-catenin. Oncogene 2008; 27:5075-80; PMID:18469861; http://dx.doi.org/10.1038/onc.2008.140
53. Li X, Deng W, Lobo-Ruppert SM, Ruppert JM. Gli1 acts through Snail and E-cadherin to promote nuclear signaling by beta-catenin. Oncogene 2007; 26:4489-98; PMID:17297467; http://dx.doi.org/10.1038/sj.onc.1210241
54. Katoh Y, Katoh M. WNT antagonist, SFRP1, is Hedgehog signaling target. Int J Mol Med 2006; 17:171-5; PMID:16328026
55. He J, Sheng T, Stelter AA, Li C, Zhang X, Sinha M, Luxon BA, Xie J. Suppressing Wnt signaling by the hedgehog pathway through sFRP-1. J Biol Chem 2006; 281:35598-602; PMID:17035233; http://dx.doi.org/10.1074/jbc.C600200200
56. Ormestad M, Astorga J, Landgren H, Wang T, Johansson BR, Miura N, Carlsson P. Foxf1 and Foxf2 control murine gut development by limiting mesenchymal Wnt signaling and promoting extracellular matrix production. Development 2006; 133:833-43; PMID:16439479; http://dx.doi.org/10.1242/dev.02252
57. Lledo S, Alfonso R, Alino SF. Antisense gene therapy using anti-k-ras and antitelomerase oligonucleotides in colorectal cancer. Rev Esp Enferm Dig 2005; 97:472-80; PMID:16262526; http://dx.doi.org/10.4321/S1130-01082005000700002
58. Halaschek-Wiener J, Wacheck V, Schlagbauer-Wadl H, Wolff K, Kloog Y, Jansen B. A novel Ras antagonist regulates both oncogenic Ras and the tumor suppressor p53 in colon cancer cells. Mol Med 2000; 6:693-704; PMID:11055588
59. Jeon HK, Choi SU, Jung NP. Association of the ERK1/2 and p38 kinase pathways with nitric oxide-induced apoptosis and cell cycle arrest in colon cancer cells. Cell Biol Toxicol 2005; 21:115-25; PMID:16142585; http://dx.doi.org/10.1007/s10565-005-0148-8
60. Thorne CA, Hanson AJ, Schneider J, Tahinci E, Orton D, Cselenyi CS, Jernigan KK, Meyers KC, Hang BI, Waterson AG, et al. Small-molecule inhibition of Wnt signaling through activation of casein kinase 1alpha. Nat Chem Biol 2010; 6:829-36; PMID:20890287; http://dx.doi.org/10.1038/nchembio.453
61. Meuillet EJ, Ihle N, Baker AF, Gard JM, Stamper C, Williams R, Coon A, Mahadevan D, George BL, Kirkpatrick L, et al. In vivo molecular pharmacology and antitumor activity of the targeted Akt inhibitor PX-316. Oncol Res 2004; 14:513-27; PMID:15559765
62. Stegh AH. Targeting the p53 signaling pathway in cancer therapy–the promises, challenges and perils. Expert Opin Ther Targets 2012; 16:67-83; PMID:22239435; http://dx.doi.org/10.1517/14728222.2011.643299
63. Baek JH, Agarwal ML, Tubbs RR, Vladisavljevic A, Tomita H, Bukowski RM, Milsom JW, Kim JM, Kwak JY. In vivo recombinant adenovirus-mediated p53 gene therapy in a syngeneic rat model for colorectal cancer. J Korean Med Sci 2004; 19:834-41; PMID:15608394; http://dx.doi.org/10.3346/jkms.2004.19.6.834
64. Xu SS, Shen WL, Ouyang SY. Inhibition of transfected PTEN on human colon cancer. World J Gastroenterol 2004; 10:3670-3; PMID:15534929
65. Suzuki H, Watkins DN, Jair KW, Schuebel KE, Markowitz SD, Chen WD, Pretlow TP, Yang B, Akiyama Y, Van Engeland M, et al. Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat Genet 2004; 36:417-22; PMID:15034581; http://dx.doi.org/10.1038/ng1330
66. Shih IM, Yu J, He TC, Vogelstein B, Kinzler KW. The beta-catenin binding domain of adenomatous polyposis coli is sufficient for tumor suppression. Cancer Res 2000; 60:1671-6; PMID:10749138
67. Satoh S, Daigo Y, Furukawa Y, Kato T, Miwa N, Nishiwaki T, Kawasoe T, Ishiguro H, Fujita M, Tokino T, et al. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Nat Genet 2000; 24:245-50; PMID:10700176; http://dx.doi.org/10.1038/73448
68. Luu HH, Zhang R, Haydon RC, Rayburn E, Kang Q, Si W, Park JK, Wang H, Peng Y, Jiang W, et al. Wnt/beta-catenin signaling pathway as a novel cancer drug target. Curr Cancer Drug Targets 2004; 4:653-71; PMID:15578921; http://dx.doi.org/10.2174/1568009043332709
69. Roh H, Green DW, Boswell CB, Pippin JA, Drebin JA. Suppression of beta-catenin inhibits the neoplastic growth of APC-mutant colon cancer cells. Cancer Res 2001; 61:6563-8; PMID:11522655
70. Green DW, Roh H, Pippin JA, Drebin JA. Beta-catenin antisense treatment decreases beta-catenin expression and tumor growth rate in colon carcinoma xenografts. J Surg Res 2001; 101:16-20; PMID:11676549; http://dx.doi.org/10.1006/jsre.2001.6241
71. van de Wetering M, Oving I, Muncan V, Pon Fong MT, Brantjes H, van Leenen D, Holstege FC, Brummelkamp TR, Agami R, Clevers H. Specific inhibition of gene expression using a stably integrated, inducible small-interfering-RNA vector. EMBO Rep 2003; 4:609-15; PMID:12776180; http://dx.doi.org/10.1038/sj.embor.embor865
72. Cong F, Zhang J, Pao W, Zhou P, Varmus H. A protein knockdown strategy to study the function of beta-catenin in tumorigenesis. BMC Mol Biol 2003; 4:10; PMID:14516475; http://dx.doi.org/10.1186/1471-2199-4-10
73. Emami KH, Nguyen C, Ma H, Kim DH, Jeong KW, Eguchi M, Moon RT, Teo JL, Kim HY, Moon SH, et al. A small molecule inhibitor of beta-catenin/CREB-binding protein transcription. Proc Natl Acad Sci U S A 2004; 101:12682-7; PMID:15314234; http://dx.doi.org/10.1073/pnas.0404875101
74. Koehne CH, Dubois RN. COX-2 inhibition and colorectal cancer. Semin Oncol 2004; 31:12-21; PMID:15252926; http://dx.doi.org/10.1053/j.seminoncol.2004.03.041
75. Subramanian F, Yamakawa A. Combination therapy targeting Raf-1 and MEK causes apoptosis of HCT116 colon cancer cells. Int J Oncol 2012; 41:1855-62; PMID:22922669
76. Agyeman A, Mazumdar T, Houghton JA. Regulation of DNA damage following termination of hedgehog (HH) survival signaling at the level of the GLI genes in human colon cancer. Oncotarget 2012; 3:854-868; PMID:23097684